Research output per year
Research output per year
Personal profile
Research interests
We are interested in delineating the biology of novel anticancer targets. Our current focus is on two proteins - the actin-binding factor profilin-1 and the polyubiquitin-specific protein segregase p97/VCP. Profilin-1 is an essential gene for eukaryotic cells, yet showing paradoxical anti-cancer activities in multiple types of human cancer. We hypothesize that it has ‘moonlighting” nuclear functions which represses the expression of various pro-cancer genes, spatially separate from its actin-regulatory activities in the cytoplasm. This “spatial confinement” model reconciles its paradoxical cellular functions and is the main focus of our research effort. In parallel, we are studying p97/VCP which is an evolutionarily conserved AAA+ ATPase regulating cellular proteostasis via facilitating the turnover of a myriad of polyubiquinated proteins within various cellular structures and protein complexes. Our current interest is its role in chromatin-associated protein degradation which occurs dynamically during DNA damage response and is crucial for maintaining genome stability.
Fingerprint
Dive into the research topics where Jieya Shao is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Cancer-associated exportin-6 upregulation inhibits the transcriptionally repressive and anticancer effects of nuclear profilin-1
Zhu, C., Kim, S. J., Mooradian, A., Wang, F., Li, Z., Holohan, S., Collins, P. L., Wang, K., Guo, Z., Hoog, J., Ma, C. X., Oltz, G., Held, J. M. & Shao, J., Feb 16 2021, In: Cell Reports. 34, 7, 108749.Research output: Contribution to journal › Article › peer-review
Open Access3 Scopus citations -
Phospho-ser784-vcp drives resistance of pancreatic ductal adenocarcinoma to genotoxic chemotherapies and predicts the chemo-sensitizing effect of vcp inhibitor
Wang, F., Vij, K., Li, L., Dodhiawala, P., Lim, K. H. & Shao, J., Oct 1 2021, In: Cancers. 13, 20, 5076.Research output: Contribution to journal › Article › peer-review
Open Access -
Ser71 Phosphorylation Inhibits Actin-Binding of Profilin-1 and Its Apoptosis-Sensitizing Activity
Wang, F., Zhu, C., Cai, S., Boudreau, A., Kim, S. J., Bissell, M. & Shao, J., Jun 21 2021, In: Frontiers in Cell and Developmental Biology. 9, 692269.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
Phospho-Ser784-VCP Is Required for DNA Damage Response and Is Associated with Poor Prognosis of Chemotherapy-Treated Breast Cancer
Zhu, C., Rogers, A., Asleh, K., Won, J., Gao, D., Leung, S., Li, S., Vij, K. R., Zhu, J., Held, J. M., You, Z., Nielsen, T. O. & Shao, J., Jun 9 2020, In: Cell Reports. 31, 10, 107745.Research output: Contribution to journal › Article › peer-review
Open Access4 Scopus citations -
Ser784 phosphorylation: a clinically relevant enhancer of VCP function in the DNA damage response
Shao, J., Sep 2 2020, In: Molecular and Cellular Oncology. 7, 5, 1796179.Research output: Contribution to journal › Comment/debate
Open Access2 Scopus citations